Beijing To Set Up International Pharmaceutical Technology Transfer Platform
This article was originally published in PharmAsia News
Executive Summary
Beijing Equity Exchange, Capital Science & Technology Group and China Center for Pharmaceutical International Exchange recently signed an agreement to jointly establish a platform providing special services for pharmaceutical corporations, R&D institutions and investment organizations. The platform aims to forge a complete pharmaceutical technology transfer service chain for consultation, assessment, investment, acquisition and reorganization. Its competitive advantages include: comprehensive equity exchange system and facilities; worldwide information distribution network; abundant investment resources; international collaboration channels; and capability to integrate medical research institutions. (Click here for more - Chinese Language)